These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 399251)

  • 21. Peritoneal fibrosis due to practolol. Scanning electron microscopical and histological observations.
    Myllärniemi H; Leppäniemi A
    Acta Chir Scand; 1981; 147(2):137-42. PubMed ID: 7324743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the antihypertensive effect of propranolol and practolol combined with chlorthalidone.
    Geyskes GG; Stutterheim A; Boer P; Mees EJ
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):85-90. PubMed ID: 786689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction.
    Mackie IA; Seal DV; Pescod JM
    Br J Ophthalmol; 1977 May; 61(5):354-9. PubMed ID: 17431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practolol and deafness.
    Jones RF; Hammond VT; Wright D; Ballantyne JC
    J Laryngol Otol; 1977 Nov; 91(11):963-72. PubMed ID: 145453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management.
    Eltringham WK; Espiner HJ; Windsor CW; Griffiths DA; Davies JD; Baddeley H; Read AE; Blunt RJ
    Br J Surg; 1977 Apr; 64(4):229-35. PubMed ID: 856375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
    Jachuck SJ; Stephenson J; Bird T; Jackson FS; Clark F
    Postgrad Med J; 1977 Feb; 53(616):75-7. PubMed ID: 141660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.
    Amos HE; Brigden WD; McKerron RA
    Br Med J; 1975 Mar; 1(5958):598-600. PubMed ID: 1092407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of clonidine and practolol in the treatment of hypertension.
    Pitkäjärvi T; Ala-Laurila P; Torsti P; Ruosteenoja R
    Ann Clin Res; 1976 Feb; 8(1):48-54. PubMed ID: 779587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology of practolol-induced ocular toxicity.
    Rahi AH; Chapman CM; Garner A; Wright P
    Br J Ophthalmol; 1976 May; 60(5):312-23. PubMed ID: 952801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of practolol in supraventricular arrhythmias associated with acute illnesses.
    Pribble AH; Conn RD
    Am J Cardiol; 1975 May; 35(5):645-50. PubMed ID: 1124718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sclerosing peritonitis and practolol (author's transl)].
    Hess T; Stucki P
    Med Klin; 1977 Jul; 72(28-29):1220-4. PubMed ID: 887049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reaction of peripheral veins and arteries following administration of beta-active agents. Studies on isoproterenol, propranolol, and practolol].
    Bischoff K; Larsen N; Mucha C; Westermann KW
    Med Klin; 1976 Jul; 71(30):1239-43. PubMed ID: 940512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Review: beta-blocking agents in dermatology (author's transl)].
    Clerens A; Guilmot-Bruneau MM; Defresne C; Bourlond A
    Dermatologica; 1981; 163(1):5-11. PubMed ID: 6115777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of two beta-adrenergic blocking drugs in angina pectoris.
    Stroescu V; Theodorini S; Creţescu R
    Rev Roum Med Intern; 1974; 11(3):307-11. PubMed ID: 4152108
    [No Abstract]   [Full Text] [Related]  

  • 35. The value of patch and other skin tests in drug eruptions.
    Felix RH; Comaish JS
    Lancet; 1974 May; 1(7865):1017-9. PubMed ID: 4133700
    [No Abstract]   [Full Text] [Related]  

  • 36. Test and teach. Number twenty-one. Diagnosis: practolol induced sclerosing peritonitis.
    Chang AR
    Pathology; 1980 Jan; 12(1):32-33, 131-3. PubMed ID: 7375145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological changes and practolol.
    Amos HE; Brigden WD
    Lancet; 1976 Dec; 2(7998):1298. PubMed ID: 63765
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of a selective beta adrenergic blocking agent on ventricular arrhythmias in the first year following myocardial infarction.
    Federman J; Whitford JA; Anderson ST; Pitt A
    Aust N Z J Med; 1980 Jun; 10(3):289-94. PubMed ID: 6996660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Practolol: a new beta-blocking agent].
    Warembourg H; Ducloux G
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1316-25. PubMed ID: 4802743
    [No Abstract]   [Full Text] [Related]  

  • 40. A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol.
    Mann RD
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):705-10. PubMed ID: 16088980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.